Información de Medicamentos AHFS.
Bethesda, Md: American Society of Health-System Pharmacists; 2000:2306 - 2307.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol. 1991;31:251 - 255.
Walker BR, Edwards CR. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.
Endocrinol Metab Clin North Am.
1994;23:359 - 377.
Wash LK, Bernard JD. Licorice-induced pseudoaldosteronism.
Am J Hosp Pharm.
1975;32:73 - 74.
Blachley JD, Knochel JP. Tobacco chewer's hypokalemia: licorice revisited.
N Engl J Med. 1980;302:784 - 785.
Good CB, McDermott L, McCloskey B. Diet and serum potassium in patients on ACE inhibitors [letter].
JAMA.
1995;274:538.
Warren SE, O'Connor DT. Hyperkalemia resulting from captopril administration.
JAMA.
1980;244:2551 - 2552.
Grossman A, Eckland D, Price P, et al. Captopril: reversible renal failure with severe hyperkalaemia [letter].
Lanceta.
1980;1:712.
Burnakis TG, Mioduch HJ. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
Arch Intern Med.
1984;144:2371 - 2372.
Stoltz ML, Andrews CE Jr. Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use.
JAMA.
1990;264:2737 - 2738.
Golik A, Modai D, Averbukh Z, et al. Zinc metabolism in patients treated with captopril versus enalapril.
Metabolismo.
1990;39:665 - 667.
Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients.
J Am Coll Nutr.
1998;17:75 - 80.
Lee SC, Park SW, Kim DK, et al. Iron supplementation inhibits cough associated with ACE inhibitors.
Hipertensión.
2001;38:166 - 170.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.